Cargando…

Chemokine Receptors as Biomarkers in Multiple Sclerosis

Leukocyte infiltrates characterize tissue inflammation and are thought to be integral in the pathogenesis of multiple sclerosis (MS). This attribute underlines the importance of understanding mechanisms of leukocyte migration. Chemokines are secreted proteins which govern leukocyte trafficking into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fox, Robert J., Kivisäkk, Pia, Lee, Jar-Chi, Tucky, Barbara, Lucchinetti, Claudia, Rudick, Richard A., Ransohoff, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2006
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850832/ https://www.ncbi.nlm.nih.gov/pubmed/17124344 http://dx.doi.org/10.1155/2006/694283

Ejemplares similares

Human cerebrospinal fluid contains CD4+ memory T cells expressing gut- or skin-specific trafficking determinants: relevance for immunotherapy
por: Kivisäkk, Pia, et al.
Publicado: (2006)

Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis
por: Rudick, Richard A., et al.
Publicado: (2011)

Human Brain Microvascular Endothelial Cells and Umbilical Vein Endothelial Cells Differentially Facilitate Leukocyte Recruitment and Utilize Chemokines for T Cell Migration
por: Man, Shumei, et al.
Publicado: (2008)

Editorial Research Topic “Chemokines and chemokine receptors in brain homeostasis”
por: Ransohoff, Richard M., et al.
Publicado: (2015)

Chemokines and Chemokine Receptors in Multiple Sclerosis
por: Cheng, Wenjing, et al.
Publicado: (2014)

The role of chemokines and chemokine receptors in multiple sclerosis
por: Cui, Li-Yuan, et al.
Publicado: (2020)

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
por: Rudick, Richard A., et al.
Publicado: (2014)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Biomarkers in Multiple Sclerosis: Role of Antibodies
por: Berger, Thomas, et al.
Publicado: (2006)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

NMO-IgG: A Specific Biomarker for Neuromyelitis Optica
por: Weinshenker, Brian G., et al.
Publicado: (2006)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Dhaiban, Sarah, et al.
Publicado: (2020)

Animal models of multiple sclerosis: the good, the bad and the bottom line
por: Ransohoff, Richard M
Publicado: (2012)

Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis
por: Waubant, Emmanuelle
Publicado: (2006)

Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis
por: Huang, DeRen, et al.
Publicado: (2001)

Meningeal and cortical grey matter pathology in multiple sclerosis
por: Gh Popescu, Bogdan F, et al.
Publicado: (2012)

Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis
por: Regev, Keren, et al.
Publicado: (2016)

Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers
por: O’Connor, Kevin C., et al.
Publicado: (2006)

Increased Intrathecal Chemokine Receptor CCR2 Expression in Multiple Sclerosis
por: Nakajima, Hideto, et al.
Publicado: (2007)

Treatment of Cognitive Impairment in Multiple Sclerosis
por: Pierson, Susan H., et al.
Publicado: (2006)

Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica
por: Uzawa, Akiyuki, et al.
Publicado: (2010)

Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
por: Motl, Robert W, et al.
Publicado: (2017)

A Protective Role for ELR+ Chemokines during Acute Viral Encephalomyelitis
por: Hosking, Martin P., et al.
Publicado: (2009)

Effect of Natalizumab Treatment on Circulating Plasmacytoid Dendritic Cells: A Cross-Sectional Observational Study in Patients with Multiple Sclerosis
por: Kivisäkk, Pia, et al.
Publicado: (2014)

Risk of Multiple Sclerosis in Epstein–Barr Virus Infection
por: Ahmed, Syed Ijlal, et al.
Publicado: (2019)

Regulation of class II major histocompatibility complex genes: Relation to multiple sclerosis
por: Ransohoff, R.M.
Publicado: (1989)

Tissue donations for multiple sclerosis research: current state and suggestions for improvement
por: Vanderdonckt, Patrick, et al.
Publicado: (2022)

Molecular Network Analysis of T-Cell Transcriptome Suggests Aberrant Regulation of Gene Expression by NF-κB As a Biomarker for Relapse of Multiple Sclerosis
por: Satoh, Jun-ichi, et al.
Publicado: (2008)

Depression and Cognitive Impairment in Disability-Free Early Multiple Sclerosis
por: Haase, Claus G., et al.
Publicado: (2003)

Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation
por: Cardona, Astrid E, et al.
Publicado: (2008)

CC Chemokine Receptor 2 is Protective Against Noise-Induced Hair Cell Death: Studies in CX3CR1(+/GFP) Mice
por: Sautter, Nathan B., et al.
Publicado: (2006)

Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
por: Benedict, Ralph HB, et al.
Publicado: (2017)

Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis
por: Bakshi, Rohit, et al.
Publicado: (2016)

Molecular Profiling of Glatiramer Acetate Early Treatment Effects in Multiple Sclerosis
por: Achiron, Anat, et al.
Publicado: (2009)

The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis
por: Feys, Peter, et al.
Publicado: (2017)

The relation between inflammation and neurodegeneration in multiple sclerosis brains
por: Frischer, Josa M., et al.
Publicado: (2009)

The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
por: Davidsson, Pia, et al.
Publicado: (2005)

Biomolecular alterations detected in multiple sclerosis skin fibroblasts using Fourier transform infrared spectroscopy
por: Wilkins, Jordan M., et al.
Publicado: (2023)

Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability
por: Brier, Matthew R., et al.
Publicado: (2021)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_a5qmfphumi70g9hng1m2erji78